Examined lymph node counts ≤6 are correlated with an unfavorable prognosis in stage IA NSCLC patients following sublobar resection: a retrospective study employing propensity score matching analysis.

IF 1.9 3区 医学 Q3 RESPIRATORY SYSTEM
Journal of thoracic disease Pub Date : 2026-03-31 Epub Date: 2026-02-26 DOI:10.21037/jtd-2025-aw-2137
Yufeng Tang, Min Luo
{"title":"Examined lymph node counts ≤6 are correlated with an unfavorable prognosis in stage IA NSCLC patients following sublobar resection: a retrospective study employing propensity score matching analysis.","authors":"Yufeng Tang, Min Luo","doi":"10.21037/jtd-2025-aw-2137","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Complete lymph node dissection improves staging accuracy in non-small cell lung cancer (NSCLC) patients and may improve outcomes in select patients. However, the benefit of increased lymph node examination in patients with stage IA NSCLC remains unclear. Therefore, this study aimed to explore the relationship between the examined lymph node (ELN) counts and the prognosis of patients with stage IA NSCLC following sublobar resection.</p><p><strong>Methods: </strong>We obtained data from the Surveillance, Epidemiology, and End Results (SEER) 17 registry study database (2010-2019), including patients with stage IA NSCLC who underwent sublobar resection. Patients with missing ELN counts were excluded. Cox regression analysis showed a correlation between ELN count and cancer-specific survival (CSS). Propensity score matching (PSM) compared survival between ELN ≤6 and ELN >6 groups. Analysis used Empower Stats and R software.</p><p><strong>Results: </strong>In this study, 5,851 patients with NSCLC and pathological stage IA disease were included. Patients with more than 6 ELNs were older, more likely to be Caucasian, and more likely to have lung adenocarcinoma. After PSM, baseline characteristics were balanced between ELN groups. Univariate analysis showed better survival in the ELN >6 group, with a hazard ratio (HR) of 0.75 [95% confidence interval (CI): 0.64-0.88, P=0.0004], which was consistent in multivariate analysis (HR: 0.76, 95% CI: 0.64-0.89, P=0.0008). Kaplan-Meier survival curves indicated significantly better survival in the ELN >6 group, consistent across wedge and segmental resection subgroups.</p><p><strong>Conclusions: </strong>In conclusion, our findings indicate that an ELN count of ≤6 following sublobar resection in patients with stage IA NSCLC is linked to an unfavorable prognosis. We recommend dissecting more than 6 nodes during sublobar resections in stage 1A NSCLC patients.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"18 3","pages":"210"},"PeriodicalIF":1.9000,"publicationDate":"2026-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13077378/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-2025-aw-2137","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Complete lymph node dissection improves staging accuracy in non-small cell lung cancer (NSCLC) patients and may improve outcomes in select patients. However, the benefit of increased lymph node examination in patients with stage IA NSCLC remains unclear. Therefore, this study aimed to explore the relationship between the examined lymph node (ELN) counts and the prognosis of patients with stage IA NSCLC following sublobar resection.

Methods: We obtained data from the Surveillance, Epidemiology, and End Results (SEER) 17 registry study database (2010-2019), including patients with stage IA NSCLC who underwent sublobar resection. Patients with missing ELN counts were excluded. Cox regression analysis showed a correlation between ELN count and cancer-specific survival (CSS). Propensity score matching (PSM) compared survival between ELN ≤6 and ELN >6 groups. Analysis used Empower Stats and R software.

Results: In this study, 5,851 patients with NSCLC and pathological stage IA disease were included. Patients with more than 6 ELNs were older, more likely to be Caucasian, and more likely to have lung adenocarcinoma. After PSM, baseline characteristics were balanced between ELN groups. Univariate analysis showed better survival in the ELN >6 group, with a hazard ratio (HR) of 0.75 [95% confidence interval (CI): 0.64-0.88, P=0.0004], which was consistent in multivariate analysis (HR: 0.76, 95% CI: 0.64-0.89, P=0.0008). Kaplan-Meier survival curves indicated significantly better survival in the ELN >6 group, consistent across wedge and segmental resection subgroups.

Conclusions: In conclusion, our findings indicate that an ELN count of ≤6 following sublobar resection in patients with stage IA NSCLC is linked to an unfavorable prognosis. We recommend dissecting more than 6 nodes during sublobar resections in stage 1A NSCLC patients.

一项采用倾向评分匹配分析的回顾性研究表明,IA期NSCLC患者叶下切除术后淋巴结计数≤6与预后不良相关。
背景:完全淋巴结清扫可以提高非小细胞肺癌(NSCLC)患者的分期准确性,并可能改善部分患者的预后。然而,在IA期NSCLC患者中增加淋巴结检查的益处尚不清楚。因此,本研究旨在探讨检查淋巴结(ELN)计数与IA期NSCLC肺叶下切除术后预后的关系。方法:我们从监测、流行病学和最终结果(SEER) 17注册研究数据库(2010-2019)中获取数据,包括接受叶下切除术的IA期NSCLC患者。排除ELN计数缺失的患者。Cox回归分析显示ELN计数与肿瘤特异性生存(CSS)呈正相关。倾向评分匹配(PSM)比较ELN≤6组和ELN≤6组的生存率。分析使用Empower Stats和R软件。结果:本研究纳入5851例非小细胞肺癌伴病理IA期疾病患者。超过6个eln的患者年龄较大,更有可能是白种人,更有可能患有肺腺癌。PSM后,ELN组间基线特征平衡。单因素分析显示,ELN bbb6组生存率更高,风险比(HR)为0.75[95%可信区间(CI): 0.64-0.88, P=0.0004],多因素分析结果与此一致(HR: 0.76, 95% CI: 0.64-0.89, P=0.0008)。Kaplan-Meier生存曲线显示,在楔形和节段性切除亚组中,ELN bbb6组的生存率显著提高。结论:总之,我们的研究结果表明,IA期NSCLC患者叶下切除术后ELN计数≤6与不良预后有关。我们建议在1A期非小细胞肺癌患者的叶下切除术中清扫超过6个淋巴结。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of thoracic disease
Journal of thoracic disease RESPIRATORY SYSTEM-
CiteScore
4.60
自引率
4.00%
发文量
254
期刊介绍: The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书